Masamichi Takahashi

17PUBLICATIONS
33CO-AUTHORS
Artificial life and complex adaptive systemsGene expression (incl. microarray and other genome-wide approaches)Radiation therapyPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Nov 18, 2024
Current status and future direction of cancer research using artificial intelligence for clinical application.

Ryuji Hamamoto, Masaaki Komatsu, Masayoshi Yamada

|Aug 29, 2024
Risk Factors of Distant Recurrence and Dissemination of IDH Wild-Type Glioblastoma: A Single-Center Study and Meta-Analysis.

Takahiro Tsuchiya, Daisuke Kawauchi, Makoto Ohno

|Aug 10, 2024
The Safety and Usefulness of Awake Surgery as a Treatment Modality for Glioblastoma: A Retrospective Cohort Study and Literature Review.

Sho Osawa, Yasuji Miyakita, Masamichi Takahashi

|Oct 27, 2022
Volumetric Analysis of Glioblastoma for Determining Which CpG Sites Should Be Tested by Pyrosequencing to Predict Temozolomide Efficacy.

Tomohiro Hosoya, Masamichi Takahashi, Calvin Davey

|Sep 09, 2022
Metformin with Temozolomide for Newly Diagnosed Glioblastoma: Results of Phase I Study and a Brief Review of Relevant Studies.

Makoto Ohno, Chifumi Kitanaka, Yasuji Miyakita

|Aug 09, 2022
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.

Yohei Chiba, Kazuki Sudo, Yuki Kojima

Pageof 3

Frequent Collaborators

6 joint publications

Koichi Ichimura

5 joint publications

Yoshitaka Narita

3 joint publications

Makoto Ohno

2 joint publications

Arata Tomiyama